154 related articles for article (PubMed ID: 15088159)
1. [Prothrombotic factors in stroke].
Meseguer E; Llamas P; Fernández de Velasco J; García A; Echevarria A; Oña R; Rábano J; Tomas JF; García de Yébenes J
Neurologia; 2004 Apr; 19(3):99-105. PubMed ID: 15088159
[TBL] [Abstract][Full Text] [Related]
2. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.
Kennedy M; Andreescu AC; Greenblatt MS; Jiang H; Thomas CA; Chassereau L; Wong C; Durda P; Cushman M
Br J Haematol; 2005 Feb; 128(3):386-8. PubMed ID: 15667542
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
5. Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.
Eterović D; Titlić M; Culić V; Zadro R; Primorac D
Clin Appl Thromb Hemost; 2007 Apr; 13(2):188-93. PubMed ID: 17456629
[TBL] [Abstract][Full Text] [Related]
6. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
Weger M; Renner W; Pinter O; Stanger O; Temmel W; Fellner P; Schmut O; Haas A
Eye (Lond); 2003 Aug; 17(6):731-4. PubMed ID: 12928685
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
Björkman A; Burtscher IM; Svensson PJ; Hillarp A; Besjakov J; Benoni G
Arch Orthop Trauma Surg; 2005 Feb; 125(1):51-5. PubMed ID: 15723247
[TBL] [Abstract][Full Text] [Related]
8. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family.
Corral J; Zuazu-Jausoro I; Rivera J; González-Conejero R; Ferrer F; Vicente V
Br J Haematol; 1999 May; 105(2):560-3. PubMed ID: 10233438
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
[TBL] [Abstract][Full Text] [Related]
11. [Genetics of blood coagulation in young stroke patients].
Pongrácz E; Tordai A; Csornai M; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):111-7. PubMed ID: 12122980
[TBL] [Abstract][Full Text] [Related]
12. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
[TBL] [Abstract][Full Text] [Related]
13. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Andreescu AC; Cushman M; Rosendaal FR
Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188
[TBL] [Abstract][Full Text] [Related]
14. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
15. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a case-control study and two meta-analyses.
Laugesaar R; Kahre T; Kolk A; Uustalu U; Kool P; Talvik T
Acta Paediatr; 2010 Aug; 99(8):1168-74. PubMed ID: 20337781
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
19. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
[TBL] [Abstract][Full Text] [Related]
20. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
